Back to search

National and Kapodistrian University of Athens

Ημερήσιο βιολογικό ρολόϊ κα ακετυλίωση ιστονών: μελέτη της αλληλεπίδρασης τους με τον κυτταρικό κύκλο σε in vitro συστήματα κυττάρων ποντικού

Abstract

dc:description

Circadian rhythms in biological functions are observed in a wide range of organisms. They are defined as rhythmic oscillations in physiological, metabolic and behavioral processes that are regulated by the circadian clock and display a period of about 24 hours. Central to the function of the circadian clock is the circadian oscillator, which is set by environmental time cues, but keeps circadian time in their absence. The mammalian circadian system is organized in a hierarchy of oscillators. At the top of this hierarchy is the suprachiasmatic nucleus (SCN) located in the anterior hypothalamus. The SCN is responsible for coordinating peripheral oscillators so that a coherent rhythm is orchestrated at the organismal level. The clock mechanism in the SCN and the peripheral oscillators is known to be similar at the molecular level and consists of a network of transcriptional/translational feedback loops. In vitro culture systems also exhibit circadian rhythms in gene expression, identical to those observed in vivo. In addition to controlling rhythmic expression of core clock components, these loops drive rhythmic expression of “output” genes that control physiological, metabolic and behavioral rhythms. As core clock components are defined genes, the protein products of which are necessary for generation and regulation of circadian rhythms within individual cells. In the primary feedback loop, the positive elements include transcription factors, CLOCK and BMAL1 that heterodimerize. These dimers initiate transcription of target genes containing E-box sequences in their promoters, including Per1, 2 and Cry1, 2. Negative feedback is achieved by PER/CRY dimers that translocate to the nucleus to repress their own transcription, by acting on the CLOCK/BMAL1 complex. Chromatin structure is known to determine its function. Transcriptional activation and repression are typically associated with chromatin modification. The acetylation state of a given chromatin locus is controlled by two classes of antagonizing histone modifying enzymes, histone acetyltransferases (HATs) and deacetylases (HDACs), which add or remove acetyl groups to/from target histones, respectively. Within the circadian oscillator, histone acetylation status has been found to be determining transcriptional 21 activity of positive elements, since rhythmic activation of several BMAL1/CLOCK target genes occurs in parallel with histone acetylation. Histones H3 and H4 in the promoters of Per1, 2 and Cry1 are rhythmically acetylated and maximal acetylation is observed when these genes are actively transcribed. Clock synchronization is achieved via Per1 acute response, a short and rapid induction of its transcription that is enhanced by elevated histone acetylation in its promoter. Rhythmic histone acetylation is mediated by transcriptional coactivators with HAT activity that physically interact with CLOCK. Recently, CLOCK was found to possess intrinsic HAT activity. Circadian clock function is implicated in cell cycle progression in vivo and in vitro. Since clock deregulation has been associated with increased tumor incidents and expression of Per1,2 genes is greatly reduced in several cancers, core clock components are regarded as tumor suppressors. Among circadian “output” genes are many key regulators of cell proliferation, such as Wee1 and c-Myc. The proto-oncogene c-Myc, that mediates the entry of cells in the cell cycle as well as the G1/S transition, is the only known gene, whose expression is negatively regulated by the positive clock elements BMAL1/CLOCK. However, the molecular mechanism by which circadian expression of c-Myc is achieved has not been unraveled. The bibliographic data presented above suggest that circadian clock and cell proliferation are tightly coupled. Therefore, the aim of this thesis was a) to unravel whether the c-Myc products (transcripts and protein) are under circadian clock control in cancerous cells (neuroblastoma) and b) to investigate whether circadian time is important for modulating the effects of trichostatin A (TSA), a histone deacetylase inhibitor that is known to suppress c-Myc and to constitute the basis of potential anticancer regimens. The studies were conducted in a murine neuroblastoma line, N2A. Cell cultures were clock-synchronized and expression of circadian genes was monitored for 48 hours after rhythm induction. Core clock components Bmal1, Per1,2 and Cry1 were found to oscillate with phase-differences identical to those reported for in vivo systems. Cell cycle genes Wee1 and c-Myc were also found to oscillate, indicating that in this cellular context, clock-controlled cell cycle genes function in analogy to the in vivo systems. Moreover, although Per1 is induced and c-Myc is down-regulated by positive clock elements BMAL1/CLOCK, they were found to oscillate in phase, indicating that clock 22 regulates c-Myc by additional mechanism(s) and possibly at multiple levels. To investigate this, protein levels of c-MYC were analyzed in synchronized N2A cultures. Protein accumulation was found, for the first time, to oscillate. In addition, by the use of specific inhibitors of protein synthesis and degradation, it was shown that the oncoprotein is synthesized and degraded following a rhythmic pattern. Since c-MYC acetylation regulates its stability, the acetylation pattern of the protein was analyzed in two opposite rhythmic phases. Our results showed that maximum acetylation is observed at maximum protein levels, suggesting that the balance between acetylation/deacetylation of c-MYC is regulated in a circadian manner. Rhythmic deacetylation is most likely to occur via SIRT1, a NAD-dependent deacetylase whose enzymatic activity has been proven to be controlled by the clock and to deacetylate c-MYC. Taking advantage of TSA’s properties in inducing Per1 expression and in reducing c-Myc levels, N2A cultures were treated with this histone deacetylase inhibitor at two distinct circadian times, representing the peak and the trough of Per1 and c-Myc rhythms. As expected, a 2-hour TSA treatment induced the acute response of Per1. However, a phase difference (phase-advance) of the newly induced Per1 rhythm was observed only when TSA was applied at the trough of the rhythm, indicating that TSA effects are phasedependent. Accordingly, at this specific time point only, c-Myc expression was phaseshifted and down-regulated for about 24 hours. At the same circadian time, c-MYC protein levels were profoundly reduced by TSA treatment and became arrhythmic afterwards, while they were not affected at the opposite circadian time. In nonsynchronized cultures, this reduction could be achieved only after prolonged TSA treatment. With respect to cell cycle progression, c-MYC reduction at this circadian time correlated with reduced proliferation rate of N2A cells accompanied by G1 arrest. Finally, the significance of CLOCK’s HAT activity in up-regulating Per1 and down-regulating c-Myc was explored by reporter gene assays, using wild type CLOCK or a mutated protein, lacking HAT activity. These experiments clearly demonstrated that HAT activity of CLOCK enhances Per1 induction but is dispensable for c-Myc repression by the BMAL1/CLOCK complex. They also suggest that clock transcription factors exert their effect on the oncogene by recruiting so far unknown co-factors and 23 more specifically co-repressors. Best candidates are histone deacetylases, since many of them have been shown to interact with clock elements, e.g. SIRT1. In summary, in the present thesis: a) It was presented for the first time that circadian clock regulates proto-oncogene c-Myc not only at the transcriptional level but also with respect to protein accumulation and stability. b) It was shown that effects of the histone deacetylase inhibitor trichostatin A on c-Myc mRNA and protein expression are phase-dependent, as well as that c-MYC prolonged reduction after TSA application at specific circadian time correlates with cell cycle arrest of neuroblastoma cells. c) It was indicated that positive clock elements require additional factors in order to suppress c-Myc transcription and that HAT activity of CLOCK is not involved in this mechanism. All data presented point out that the interaction between circadian clock and cell division and cancer has many yet unexplored aspects. A better understanding of the clock function on the regulation of the proto-oncogene c-Myc could be a first step in the development of new strategies to prevent and treat human malignancy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Repouskou, Anastasia
  • Ρεπούσκου, Αναστασία

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27899

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Repouskou, Anastasia; Ρεπούσκου, Αναστασία. Ημερήσιο βιολογικό ρολόϊ κα ακετυλίωση ιστονών: μελέτη της αλληλεπίδρασης τους με τον κυτταρικό κύκλο σε in vitro συστήματα κυττάρων ποντικού. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27899